SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (16966)3/9/1998 5:48:00 PM
From: WTDEC  Read Replies (1) | Respond to of 32384
 
Henry,

" Most of us are fairly convinced that the drug is the IL-2 fusion protein of SRGN"

What would be the advantages for LGND to take the IL-2 ? Is there some sort of synergy with LGND projects or is it simply to speed revenue generation?

Regards,

Walter